USE AND RESEARCH-ENTHEOGENS
SB 2184 would authorize Illinois to permit research and regulated use of psychoactive entheogens, challenging federal drug policy while enabling potential therapeutic applications.
SB 2184 would authorize Illinois to permit research and regulated use of psychoactive entheogens, challenging federal drug policy while enabling potential therapeutic applications.
SB 2184 proposes to establish a legal framework in Illinois for the use and research of entheogens (psychoactive substances with spiritual or medicinal significance, such as psilocybin mushrooms and other controlled substances). The bill would create conditions under which these substances could be studied and potentially used in regulated therapeutic or religious contexts. The bill has been reassigned multiple times and remains in the committee process as of January 2026.
This legislation represents a significant shift in drug policy, as most entheogens remain federally controlled substances. If passed, Illinois could become a leader in psychedelic research and therapy, potentially advancing treatment options for conditions like PTSD, depression, and end-of-life anxiety. However, it also creates tension between state legalization efforts and federal law, raising questions about enforcement and interstate implications.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.